Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioptron AG, a member of the Zepter Group, is a Swiss medical device company that develops and manufactures clinically tested light therapy systems used worldwide. The company's core technology, Bioptron Light Therapy, utilizes a unique combination of visible and infrared light characteristics (polarized, polychromatic, incoherent, and low-energy) to stimulate biological processes and promote tissue regeneration. Their product line, which includes the MedAll, Pro 1, and Bioptron 2 devices, is cleared for a broad range of medical indications including wound healing, dermatology, pain management, and seasonal affective disorder. Bioptron systems are utilized both in professional clinical environments and as safe, non-invasive home-use therapeutic devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioptron.